Clinical Trials for Metabolic Syndrome

Currently registered clinical trials for Metabolic Syndrome from ClinicalTrials.gov. 21 recruiting, 50 total studies.

This content is for informational purposes only. Always consult a healthcare professional.

Source: ClinicalTrials.gov — U.S. National Library of Medicine — A database of privately and publicly funded clinical studies conducted around the world (U.S. National Library of Medicine, public domain).

This page lists clinical trials related to Metabolic Syndrome from the ClinicalTrials.gov database.

Trial Summary

  • Total studies: 50
  • Recruiting: 21
  • Active, not recruiting: 7
  • Completed: 6
  • Other: 16

Results are refreshed periodically and may not reflect the most current information available from ClinicalTrials.gov.

Recruiting Trials

NCT00001456 — Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome

StatusRecruiting
PhaseN/A
SponsorNational Human Genome Research Institute (NHGRI)
Enrollment600
Study TypeOBSERVATIONAL
ConditionsHermansky-Pudlak Syndrome (HPS)

Hermansky-Pudlak Syndrome (HPS) is an inherited disease which results in decreased pigmentation (oculocutaneous albinism), bleeding problems due to a platelet abnormality (platelet storage pool defect), and storage of an abnormal fat-protein compound (lysosomal accumulation of ceroid lipofuscin).

The disease can cause poor functioning of the lungs, intestine, kidneys, or heart. The major compl…

NCT00027274 — Cancer in Inherited Bone Marrow Failure Syndromes

StatusRecruiting
PhaseN/A
SponsorNational Cancer Institute (NCI)
Enrollment4000
Study TypeOBSERVATIONAL
ConditionsDiamond Blackfan Anemia; Dyskeratosis Congenita; Fanconi Anemia; Shwachman Diamond Syndrome; Inherited Bone Marrow Failure Syndrome, Aplastic Anemia

Background:

A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders.

Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic cancers.

Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients with IBMFS who do not develop can…

NCT00055172 — Genetic Basis of Immunodeficiency

StatusRecruiting
PhaseN/A
SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Enrollment100
Study TypeOBSERVATIONAL
ConditionsSevere Combined Immunodeficiency

This study will examine the role of hereditary factors in different forms of severe combined immunodeficiency (SCID).

Patients with immunodeficiencies may be eligible for this study. Candidates include:

  • Patients with diminished numbers of T cells or NK cells or both, or
  • Patients with normal T cell and NK cell numbers but diminished T cell, B cell, or NK cell function.

Relatives of patien…

NCT00078078 — Clinical and Laboratory Study of Methylmalonic Acidemia

StatusRecruiting
PhaseN/A
SponsorNational Human Genome Research Institute (NHGRI)
Enrollment2275
Study TypeOBSERVATIONAL
ConditionsOrganic Acidemia; Methylmalonic Acidemia; Inborn Errors of Metabolism

Methylmalonic acidemia (MMA), one of the most common inborn errors of organic acid metabolism, is heterogeneous in etiology and clinical manifestations. Affected patients with cblA, cblB and mut classes of MMA are medically fragile and can suffer from complications such as metabolic stroke or infarction of the basal ganglia, pancreatitis, end stage renal failure, growth impairment, osteoporosis…

NCT00250159 — Natural History Study of Patients With Excess Androgen

StatusRecruiting
PhaseN/A
SponsorEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Enrollment3000
Study TypeOBSERVATIONAL
ConditionsCongenital Adrenal Hyperplasia (CAH); Familial Male-Limited Precocious Puberty (FMPP)

This study will evaluate and gather information in patients with genetic causes of too much androgen (male-like hormone) in order to better understand the effects of too much androgen and describe problems associated with it. Too much androgen in childhood, if untreated, results in rapid growth and early puberty with early cessation of growth and short stature in adulthood. Too much androgen in…

NCT01143454 — Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

StatusRecruiting
PhaseN/A
SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Enrollment5000
Study TypeOBSERVATIONAL
ConditionsMetabolic Disease; Obesity; Li-Fraumeni Syndrome; Cardiomyopathy; Atherosclerosis
Interventions

Background:

- Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory or genetic diseases that may put them at a high risk for heart diseases or diseases of their blood vessels. Depending on the condition being studied, both affected and nonaffected individuals may be asked to provide blood and other samples and may undergo tests to evaluate the …

NCT01443468 — Clinical and Genetic Studies of Li-Fraumeni Syndrome

StatusRecruiting
PhaseN/A
SponsorNational Cancer Institute (NCI)
Enrollment5000
Study TypeOBSERVATIONAL
ConditionsLi-Fraumeni Syndrome; Neoplasms; Tp53 Mutations

Background:

- Li-Fraumeni syndrome (LFS) is a genetic condition that increases the risk for some types of cancer. LFS may lead to cancer of the bone or connective tissue, breast, and brain. It may also increase the risk for certain types of leukemia and other cancers. The only known cause of LFS is a change (called a mutation ) in a gene known as TP53. However, not all people with LFS have a …

NCT01666080 — Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

StatusRecruiting
PhaseN/A
SponsorMasonic Cancer Center, University of Minnesota
Enrollment30
Study TypeINTERVENTIONAL
ConditionsHematologic Disorders; Hemoglobinopathies; Immunodeficiencies
Interventions; ;

This is a treatment guideline for a second or greater allogeneic hematopoietic stem cell transplant (HSCT) using a reduced intensity conditioning (RIC) in patients with non-malignant or malignant diseases. This regimen, consisting of busulfan, fludarabine, and low dose total body irradiation (TBI), is designed to promote engraftment in patients who failed to achieve an acceptable level of donor…

NCT03049462 — The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

StatusRecruiting
PhasePhase 1
SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrollment100
Study TypeINTERVENTIONAL
ConditionsPolycystic Ovary Syndrome
Interventions;

Background:

Brown adipose tissue (BAT) is a type of fat in the body. It may prevent weight gain, improve insulin sensitivity, and reduce fatty liver. Researchers want to see if BAT helps the body burn energy.

Objective:

To learn more about how BAT works to burn energy.

Eligibility:

People ages 18-40 with a body mass index between 18 and 40

Design:

Participants will be screened with:

Med…

NCT03530852 — A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

StatusRecruiting
PhaseN/A
SponsorBoston Children’s Hospital
Enrollment32
Study TypeINTERVENTIONAL
ConditionsShort Bowel Syndrome; Malabsorption
Interventions

Children with inadequate intestinal absorption due to loss of large amounts of small bowel require intravenous nutrition (feeding through the vein) to sustain hydration and nutrition to avoid starvation and dehydration; however, intravenous (IV) nutrition can lead to complications including liver failure. Tube feeding directly to the small intestine avoids the complications of IV nutrition, but…

NCT03805919 — Men at High Genetic Risk for Prostate Cancer

StatusRecruiting
PhaseN/A
SponsorNational Cancer Institute (NCI)
Enrollment500
Study TypeOBSERVATIONAL
ConditionsProstatic Neoplasms

Background:

Research studies have shown that genetic changes and family history may increase a man s risk for prostate cancer. Researchers want to follow the prostate health of men who have specific genetic changes associated with prostate cancer to help them learn more about which men are at higher risk for prostate cancer.

Objectives:

To study men with specific genetic changes and determin…

NCT04414046 — TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

StatusRecruiting
PhasePhase 2
SponsorJohns Hopkins All Children’s Hospital
Enrollment17
Study TypeINTERVENTIONAL
ConditionsPrimary Immune Deficiency Disorders; Metabolic Disease
Interventions

This research is being done to learn if a new type of haploidentical transplantation using TCR alpha beta and CD19 depleted stem cell graft from the donor is safe and effective to treat the patient’s underlying condition. This study will use stem cells obtained via peripheral blood or bone marrow from parent or other half-matched family member donor. These will be processed through a special de…

StatusRecruiting
PhaseN/A
SponsorEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Enrollment250
Study TypeOBSERVATIONAL
ConditionsSmith Lemli Opitz Syndrome; CHILD Syndrome; Lathosterolosis; Desmosterolosis

Background:

Smith-Lemli-Opitz Syndrome (SLOS) is a genetic disorder. It can cause birth defects and developmental delays. There is no cure for SLOS or other inherited diseases related to cholesterol production or storage. The data gained in this study may help researchers find ways to measure how well future treatments work.

Objective:

To learn more about SLOS and related disorders and how t…

NCT05791604 — The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics

StatusRecruiting
PhaseN/A
SponsorChildren’s Hospital of Fudan University
Enrollment60
Study TypeINTERVENTIONAL
ConditionsPrader-Willi Syndrome
Interventions;

Prader-Willi syndrome (PWS) is a rare genetic disease, with hyperappetite and severe obesity. At present, there is no effective drugs and interventions to help control the appetite of PWS patients. More and more evidence has shown that gut microbiota is closely related to obesity. Probiotics and prebiotics can improve the structure of gut microbiota, thus improve blood lipid levels and other bi…

NCT05705804 — Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

StatusRecruiting
PhaseN/A
SponsorYonsei University
Enrollment250
Study TypeINTERVENTIONAL
ConditionsDyslipidemias; Atherosclerotic Cardiovascular Disease
Interventions; ;

The purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.

NCT06500078 — Effects of Intermittent Dietary Restriction on Cardiometabolic Risk in School-aged Children

StatusRecruiting
PhaseN/A
SponsorChildren’s Hospital of Fudan University
Enrollment324
Study TypeINTERVENTIONAL
ConditionsCardiovascular Syndrome, Metabolic
Interventions;

This randomized trial aims to evaluate the health-promoting effects of intermittent dietary restrictions, including intermittent low-carbohydrate diet (ILCD) and calorie restriction (ICR), in school-aged children with cardiometabolic risk (CMR) compared with general health education based on dietary and physical activity guidelines for Chinese children.

NCT07159841 — A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

StatusRecruiting
PhasePhase 2 / Phase 3
SponsorCrinetics Pharmaceuticals Inc.
Enrollment153
Study TypeINTERVENTIONAL
ConditionsCongenital Adrenal Hyperplasia; Classic Congenital Adrenal Hyperplasia
Interventions;

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperplasia (CAH).

NCT07369011 — A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

StatusRecruiting
PhasePhase 3
SponsorEli Lilly and Company
Enrollment800
Study TypeINTERVENTIONAL
ConditionsSleep Apnea, Obstructive; Obesity; Overweight
Interventions;

The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and obesity or overweight. YDAO is a master protocol designed to support two independent studies: YSA1 and YSA2. Study YSA1 will include participants who are unable or unwilling to use Positive Airway Pressure (PAP) therapy and study YSA2 will include…

StatusRecruiting
PhaseN/A
SponsorThe Cleveland Clinic
Enrollment40
Study TypeINTERVENTIONAL
ConditionsPCOS (Polycystic Ovary Syndrome)
Interventions

The primary outcome of interest is change in PCOS health-related quality of life, while the secondary outcome of interest is change in adiposity, cardiometabolic, and inflammation biomarkers.

NCT07636928 — Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

StatusRecruiting
PhasePhase 1
SponsorViiV Healthcare
Enrollment9
Study TypeINTERVENTIONAL
ConditionsHIV Infections
Interventions; ;

The purpose of the study is to assess the bioavailability, mass balance, pharmacokinetics, metabolism and excretion of radiolabeled (14C) VH4524184.

NCT07649031 — MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients

StatusRecruiting
PhaseN/A
SponsorUniversity of Minnesota
Enrollment80
Study TypeOBSERVATIONAL
ConditionsFanconi Anemia
Interventions

This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.

Active, Not Recruiting

NCT00084305 — Analysis of Specimens From Individuals With Pulmonary Fibrosis

StatusActive, not recruiting
PhaseN/A
SponsorNational Human Genome Research Institute (NHGRI)
Enrollment315
Study TypeOBSERVATIONAL
ConditionsPulmonary Fibrosis; Healthy Volunteers; Hermansky-Pudlak Syndrome (HPS)

The etiology of pulmonary fibrosis is unknown. Analyses of blood, genomic DNA, and specimens procured by bronchoscopy, lung biopsy, lung transplantation, clinically-indicated extra-pulmonary biopsies, or post-mortem examination from individuals with this disorder may contribute to our understanding of the pathogenic mechanisms of pulmonary fibrosis. The purpose of this protocol is to procure an…

NCT02912559 — Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

StatusActive, not recruiting
PhasePhase 3
SponsorNational Cancer Institute (NCI)
Enrollment712
Study TypeINTERVENTIONAL
ConditionsColon Adenocarcinoma; DNA Repair Disorder; Lynch Syndrome; Stage III Colon Cancer AJCC v8
Interventions; ;

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair (dMMR). Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different ways to stop the growth …

NCT03655223 — Early Check: Expanded Screening in Newborns

StatusActive, not recruiting
PhaseN/A
SponsorRTI International
Enrollment30000
Study TypeOBSERVATIONAL
ConditionsSpinal Muscular Atrophy; Fragile X Syndrome; Fragile X - Premutation; Duchenne Muscular Dystrophy; Hyperinsulinemic Hypoglycemia, Familial 1
Interventions

Early Check provides voluntary screening of newborns for a selected panel of conditions. The study has three main objectives: 1) develop and implement an approach to identify affected infants, 2) address the impact on infants and families who screen positive, and 3) evaluate the Early Check program. The Early Check screening will lead to earlier identification of newborns with rare health condi…

NCT05003648 — Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy

StatusActive, not recruiting
PhasePhase 4
SponsorMassachusetts General Hospital
Enrollment24
Study TypeINTERVENTIONAL
ConditionsAdrenoleukodystrophy; Restless Legs Syndrome
Interventions;

The investigators recently observed that up to 25% of women with X-linked adrenoleukodystrophy (ALD) have moderate to severe Restless Leg Syndrome (RLS). In this study, the investigators aim to estimate the prevalence of RLS among women with ALD and to assess whether pramipexole improves RLS symptoms as well as sleep and gait measures in women with ALD.

NCT05632601 — Reexamining Her Cardiovascular Risk - Ottawa WomeN’s Longitudinal Cohort Study

StatusActive, not recruiting
PhaseN/A
SponsorOttawa Heart Institute Research Corporation
Enrollment176
Study TypeINTERVENTIONAL
ConditionsCardiovascular Diseases
Interventions

The full HER CROWN will be a prospective cohort study to propose a novel, women-specific cardiovascular risk score/ algorithm in the prediction of hard cardiovascular outcomes (myocardial infarction, unstable angina, coronary revascularization, stroke, total and cardiovascular mortality). This future study will be the first longitudinal cohort study, to our knowledge, that is focused entirely o…

NCT06807463 — A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease

StatusActive, not recruiting
PhasePhase 2
SponsorTeva Branded Pharmaceutical Products R&D LLC
Enrollment50
Study TypeINTERVENTIONAL
ConditionsCeliac Disease
Interventions;

The primary efficacy objective of the trial is to assess the ability of TEV-53408 to attenuate gluten-induced enteropathy in adults with celiac disease.

The primary safety objective of the trial is to assess the safety of TEV-53408 in adults with celiac disease.

A secondary objective is to further assess the efficacy of TEV-53408 in adults with celiac disease.

The expected trial duration per…

NCT06961344 — An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)

StatusActive, not recruiting
PhasePhase 2
SponsorTisento Therapeutics
Enrollment44
Study TypeINTERVENTIONAL
ConditionsMitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Interventions

The goal of this clinical trial is to evaluate the long-term safety and tolerability of zagociguat in patients with MELAS who completed study medication treatment in the lead-in study TIS6463-203. TIS6463-204 is evaluating zagociguat in an open-label extension study at the daily dose of 15mg. The study medication is a once daily oral table and will be provided at the clinic and/or shipped to th…

Not Yet Recruiting

NCT07688265 — Effect of Obesity Phenotype on Intraabdominal Pressure and Bleeding in Major Lumbar Spinal Surgery

StatusNot yet recruiting
PhaseN/A
SponsorMarmara University Pendik Training and Research Hospital
Enrollment90
Study TypeOBSERVATIONAL
ConditionsLumbar Spinal Stenosis; Lumbar Degenerative Disease; Obesity; Intraabdominal Hypertension; Intraoperative Blood Loss
Interventions;

Obesity is prevalent among patients with lumbar degenerative disease and is a known risk factor for perioperative complications in spinal surgery. However, most existing evidence relies solely on body mass index (BMI) without distinguishing between central and peripheral obesity phenotypes. Central and peripheral fat distribution may have distinct biomechanical and hemodynamic consequences, par…

NCT07684469 — Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia

StatusNot yet recruiting
PhasePhase 4
SponsorNovartis Pharmaceuticals
Enrollment300
Study TypeINTERVENTIONAL
ConditionsAcute Coronary Syndrome
Interventions;

This study aims to evaluate the effectiveness and safety of implementing a systematic augmented low-density lipoprotein cholesterol (LDL-C) management care pathway initiated in hospitals for patients with Acute Coronary Syndrome. This pathway includes treatment with inclisiran on top of the standard of care (SOC), which consists of statins with or without ezetimibe, compared to a high-intensity…

NCT07611786 — Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia

StatusNot yet recruiting
PhaseN/A
SponsorUniversity of Alabama at Birmingham
Enrollment40
Study TypeOBSERVATIONAL
ConditionsCongenital Adrenal Hyperplasia
Interventions

The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on transition readiness, disease-specific self-management knowledge, emergency preparedness, continuity of endocrine care, …

NCT07687667 — Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS

StatusNot yet recruiting
PhaseN/A
SponsorPeking University Third Hospital
Enrollment406
Study TypeINTERVENTIONAL
ConditionsPolycystic Ovary Syndrome (PCOS); Obesity; Infertility, Female
Interventions;

The goal of this clinical trial is to examine whether GLP1-RA and healthy lifestyle education in women with PCOS and obesity prior to fertility treatment improves live birth rate and other reproductive, maternal and perinatal outcomes compared to metformin plus healthy lifestyle education.

NCT07005297 — Clinical Genetics Branch Eligibility Screening Survey

StatusNot yet recruiting
PhaseN/A
SponsorNational Cancer Institute (NCI)
Enrollment1000
Study TypeOBSERVATIONAL
ConditionsMelanoma; Li-Fraumeni Syndrome; Pulmonary Blastoma; Chordoma; Congenital Bone Marrow Failure Syndromes

Background:

Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer in order to improve our understanding of cancer and to improve cancer care. There are currently 6 open clinical genetics studies at the CGB eligible for this screening process.

  • 02C0052: Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndr…

NCT07313787 — Effects of Meal Macronutrients on Postprandial Lipids

StatusNot yet recruiting
PhasePhase 2
SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrollment100
Study TypeINTERVENTIONAL
ConditionsNephrotic Syndrome; Lipodystrophy; Metabolic Syndrome; Healthy Volunteer; Diabetes
Interventions;

Background:

Abnormal fats in the blood can lead to many problems, including heart disease. Researchers want to learn more about how eating meals with different levels of nutrients affects fats in the blood. Specifically, they want to study people with too much body fat, too little body fat, and a kidney problem called nephrotic syndrome.

Objective:

To learn more about how different types of …

NCT07680816 — Metabolic and Functional Study of γδ T Cells in Critically Ill Patients

StatusNot yet recruiting
PhaseN/A
SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
Enrollment105
Study TypeOBSERVATIONAL
ConditionsSepsis; Critical Illness; Immunosuppression; MODS; Mitochondrial Diseases

This prospective observational cohort study investigates the subset-specific metabolic adaptation and functional remodeling of cytotoxic γδT cells in critically ill patients with and without sepsis. Emerging evidence indicates that γδT cells, as a bridge between innate and adaptive immunity, play a critical role in early anti-infection defense during sepsis. However, the functional status and u…

NCT07240649 — Emerging Indications for Hyperbaric Oxygen Treatment

StatusNot yet recruiting
PhasePhase 4
SponsorJay C. Buckey Jr.
Enrollment100
Study TypeINTERVENTIONAL
ConditionsPost-COVID-19 Condition; Ulcerative Colitis; Crohn Disease; Calciphylaxis; Frostbite
Interventions;

This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The re…

NCT07685639 — Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study

StatusNot yet recruiting
PhaseN/A
SponsorUniversity of Alberta
Enrollment2000
Study TypeINTERVENTIONAL
ConditionsACS (Acute Coronary Syndrome); Hyperlipidemia; Dyslipidemia; Low-Density-Lipoprotein-cholesterol Level
Interventions

The purpose of this study is to determine whether a proactive, EHR-guided approach helps more individuals reach safe cholesterol levels, improves medication use, and reduces future heart attacks and strokes, compared to usual care.

The main question it aims to answer is:

• Does the EHR-LOCALE pathway increases the proportion of patients who reach the LDL-cholesterol target of <1.8 mmol/L at …

NCT07687264 — Assessment of Metabolic Changes in Response to Glcuose Intake in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS)

StatusNot yet recruiting
PhaseN/A
SponsorUniversity of Zurich
Enrollment40
Study TypeINTERVENTIONAL
ConditionsPCOS (Polycystic Ovary Syndrome); Insulinemic Response; Overweight (BMI > 25)
Interventions

Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome (PCOS), is a common endocrine and metabolic condition affecting women of reproductive age. It is associated with hormonal imbalances, irregular menstrual cycles, elevated androgen levels, and metabolic disturbances such as insulin resistance. These metabolic changes can increase the risk of type 2 dia…

Enrolling by Invitation

NCT00895271 — Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders

StatusEnrolling by invitation
PhaseN/A
SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Enrollment200
Study TypeOBSERVATIONAL
ConditionsPrimary Immunodeficiency; DOCK8; Virus Susceptibility

Background:

  • National Institutes of Health (NIH) researchers have been studying immune cells (white blood cells) to better understand how the human body s defense system works and adjusts or regulates itself, and how changes in this system can make a person sick.
  • To study the cells of patients who have problems with their immune systems, researchers would like to collect samples of skin cel…

NCT05635747 — A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB

StatusEnrolling by invitation
PhaseN/A
SponsorBoston Children’s Hospital
Enrollment32
Study TypeOBSERVATIONAL
ConditionsShort Bowel Syndrome; Malabsorption
Interventions

Children with inadequate intestinal absorption due to loss of large amounts of small bowel require intravenous nutrition (feeding through the vein) to sustain hydration and nutrition to avoid starvation and dehydration; however, intravenous (IV) nutrition can lead to complications including liver failure. Tube feeding directly to the small intestine avoids the complications of IV nutrition, but…

NCT07686601 — Metabolic Effectiveness of Extracorporeal Shockwave on Abdominal Adiposity

StatusEnrolling by invitation
PhaseN/A
SponsorCairo University
Enrollment90
Study TypeINTERVENTIONAL
ConditionsAbdominal Obesity; Abdominal Obesity-Metabolic Syndrome; Abdominal Obesity in Young and Middle Aged Adults
Interventions; ;

Egyptian Ministry of Health and Population’s Preventive Sector, have named obesity as one of the top contributors to the national mortality and morbidity. Abdominal obesity is a strong predictor of metabolic disorders and premature mortality. Visceral fat is metabolically active and sensitive for lipolysis, unless it is more insulin resistant. It is well-known that overweight and/ or obesity is…

NCT07688694 — Development of Anti-Diabetic Nutraceuticals From Legume Seed Coats

StatusEnrolling by invitation
PhaseN/A
SponsorJSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH
Enrollment100
Study TypeINTERVENTIONAL
ConditionsPostprandial Hyperglycemia; Type 2 Diabetes; Metabolic Syndromes
Interventions

This open-label clinical trial aims to evaluate whether daily consumption of soup prepared from boiled water extracts of selected legume seed coats, seasoned with salt and spices, improves glycemic regulation in individuals with metabolic syndrome or type 2 diabetes mellitus (T2DM). The primary question is whether daily intake of this palatable legume-based soup enhances glycemic control. Secon…

Completed Trials

NCT00001721 — Study of Smith-Lemli-Opitz Syndrome

StatusCompleted
PhaseN/A
SponsorEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Enrollment130
Study TypeOBSERVATIONAL
ConditionsSmith-Lemli-Opitz Syndrome
Interventions; ;

Smith-Lemli-Opitz Syndrome (SLOS) is a genetic disorder (autosomal recessive) caused by an abnormality in the production of cholesterol. The disorder can occur in both a “mild” or “severe” form. SLOS is associated with multiple birth defects and mental retardation. Some of the birth defects include; abnormal facial features, poor muscle tone, poor growth, shortened life span, and abnormalities …

NCT00001813 — Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

StatusCompleted
PhaseN/A
SponsorNational Cancer Institute (NCI)
Enrollment709
Study TypeOBSERVATIONAL
ConditionsCockayne Syndrome; Skin Neoplasms; Xeroderma Pigmentosum; Trichothiodystrophy Syndromes; Genodermatosis

Four rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), the XP/CS complex and trichothiodystrophy (TTD) have defective DNA excision repair although only XP has increased cancer susceptibility. We plan to perform careful clinical examination of selected patients with XP, XP/CS, CS, or TTD and follow their clinical course. We will obtain tissue (skin, blood, hair, buccal s…

NCT00040222 — Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

StatusCompleted
PhaseN/A
SponsorNational Cancer Institute (NCI)
Enrollment377
Study TypeOBSERVATIONAL
ConditionsFamilial Ovarian Cancer; Familial Breast Cancer; BRCA1-associate Malignancies; BRCA2-associated Malignancies

Individuals and families with known or suspected syndromes that include breast, ovarian or genetically-related cancers are enrolled in this family study, which is a syndrome-specific sub-set of the long-standing DCEG Human Genetics Program umbrella family studies protocol (78-C-0039). Cancer outcomes are documented through review of medical, vital, and pathology records. Selected individuals an…

StatusCompleted
PhaseN/A
SponsorEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Enrollment342
Study TypeOBSERVATIONAL
ConditionsLysosomal Storage Disease; Cholesterol Metabolism

This study will investigate the cause and medical problems associated with a group of genetic disorders known as inborn errors of cholesterol synthesis, in which the body does not produce cholesterol. People with this disorder may have birth defects and learning and behavioral problems.

People with an inborn error of cholesterol synthesis and related disorders, including Smith-Lemli-Opitz synd…

NCT07686939 — Clinical Validation of Continuous Glucose Monitoring in Glycemic Management of Critically Ill Sepsis Patients

StatusCompleted
PhaseN/A
SponsorTaizhou Hospital
Enrollment60
Study TypeOBSERVATIONAL
ConditionsSepsis; Hyperglycemia; Glycemic Control
Interventions

Poor glycemic control is common in critically ill patients with sepsis and is associated with increased morbidity and mortality; however, achieving safe and effective glucose management in the ICU remains challenging with conventional intermittent monitoring. Continuous glucose monitoring (CGM) offers real-time interstitial glucose readings and has the potential to improve detection of dysglyce…

NCT06402123 — A Phase 2b Study of Zagociguat in Patients With MELAS

StatusCompleted
PhasePhase 2
SponsorTisento Therapeutics
Enrollment43
Study TypeINTERVENTIONAL
ConditionsMitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Interventions; ;

PRIZM is a Phase 2b randomized, double-blind, placebo-controlled, 3-treatment, 2-period, crossover study evaluating the efficacy and safety of oral zagociguat 15 and 30 mg vs. placebo when administered daily for 12 weeks in participants with genetically and phenotypically defined MELAS.

Other (Suspended)

NCT02506946 — NAFLD in Adolescents and Young Adults With PCOS

StatusSuspended
PhaseN/A
SponsorColumbia University
Enrollment80
Study TypeOBSERVATIONAL
ConditionsPolycystic Ovary Syndrome; Non-Alcoholic Fatty Liver Disease; Metabolic Syndrome

This project focuses on an at-risk adolescent and young adult population who may gain long-term health benefits from detection of risk factors at a young age. The primary aims of this proposal are: 1) To observe whether adolescents and young adults with Polycystic Ovary Syndrome (PCOS) are more likely to have elevated liver fat (>/=4.8%) than controls by studying liver fat deposition measured …

Other (Withdrawn)

NCT05716607 — Treatment Study in Patients Treated With Both Insulin & Hydrocortisone

StatusWithdrawn
PhaseN/A
SponsorVastra Gotaland Region
EnrollmentN/A
Study TypeINTERVENTIONAL
ConditionsDiabetes Mellitus; Adrenal Insufficiency; Polyglandular Autoimmune Syndrome
Interventions;

The aim of INS.CORT trial is, by studying glycemic variability in a well-defined patient group with both insulin & hydrocortisone (patients with concomitant insulin-treated diabetes & Addison’s disease) and collecting information about the administration -time point and doses- of insulin, hydrocortisone and food intake with the help of new technology to improve the treatment in all patients t…